{"totalResults":3978,"results":[{"description":"Colon cancer treatments can include surgery, radiofrequency ablation, cryosurgery, chemotherapy, radiation therapy, and targeted therapy. Learn more about the diagnosis, prognosis, and treatment of colon cancer in this expert-reviewed summary.","title":"Colon Cancer Treatment (PDQ®)\u2013Patient Version - National Cancer Institute","contentType":"pdqCancerInfoSummary","url":"https://www.cancer.gov/types/colorectal/patient/colon-treatment-pdq"},{"description":"Colon cancer treatment often involves open surgical resection as the primary treatment for localized disease. Other modalities include chemotherapy, targeted therapy, radiation therapy, and local ablation. Get detailed information about colon cancer treatment in this summary for clinicians.","title":"Colon Cancer Treatment (PDQ®)\u2013Health Professional Version - National Cancer Institute","contentType":"pdqCancerInfoSummary","url":"https://www.cancer.gov/types/colorectal/hp/colon-treatment-pdq"},{"description":"NCI supports clinical trials studying new and more effective ways to detect and treat cancer. Find prevention clinical trials for colon cancer.","title":"Prevention Clinical Trials for Colon Cancer - National Cancer Institute","contentType":"nciAppModulePage","url":"https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/colon-cancer/prevention"},{"description":"NCI supports clinical trials studying new and more effective ways to detect and treat cancer. Find treatment clinical trials for colon cancer.","title":"Treatment Clinical Trials for Colon Cancer - National Cancer Institute","contentType":"nciAppModulePage","url":"https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/colon-cancer/treatment"},{"description":"A Cancer Currents blog on a study which showed a shorter chemotherapy course following surgery may be preferred for some patients with colon cancer.","title":"Less Adjuvant Chemotherapy for Colon Cancer - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/news-events/cancer-currents-blog/2017/adjuvant-chemo-colorectal"},{"description":"In this phase III trial, people who have had curative surgery for colon cancer will be randomly assigned to take sulindac and a placebo, eflornithine and a placebo, both sulindac and eflornithine, or two placebo pills for 36 months.","title":"Preventing Second Cancers in Colon Cancer Survivors - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/types/colorectal/research/eflornithine-sulindac"},{"description":"NCI funded researchers identified a gene mutation that greatly increases the risk of colon cancer. Gregg, a carrier of the mutation, participated in an NCI-funded clinical trial testing a drug combination to reduce the burden of colon polyps.","title":"Leveraging Biology to Prevent Familial Colon Cancer - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/research/progress/discovery/gregg-prevent-familial-colon-cancer"},{"description":"Findings from a proteogenomic study of colon cancer by NCI\u2019s Clinical Proteomic Tumor Analysis Consortium may guide new treatment strategies.","title":"Proteogenomic Study Reveals New Details of Colon Cancer - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/proteogenomics-cptac-colon-cancer"},{"description":"In this study, researchers will engineer three models to examine the microenvironment in both the primary site and metastatic sites of colon cancer.","title":"An Organotypic Model Recapitulating Colon Cancer Microenvironment and Metastasis - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec/colon-cancer-microenvironment"},{"description":"SAS macro that projects absolute risk of colon cancer according to NCI\u2019s CCRAT algorithm. ","title":"Colon Cancer Risk Assessment - SAS Macro - National Cancer Institute","contentType":"cgvArticle","url":"https://dceg.cancer.gov/tools/risk-assessment/ccratsasmacro"}]}